Compare Sanofi India with Dr. Reddys - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs DR. REDDYS LAB - Comparison Results

SANOFI INDIA     Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DR. REDDYS LAB 
   Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the pharmaceutical value chain - basic research, finished dosages, generics, bulk actives, and biotechnology. The company's business is mainly organized into Global g... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA DR. REDDYS LAB SANOFI INDIA/
DR. REDDYS LAB
 
P/E (TTM) x 39.3 40.8 96.5% View Chart
P/BV x 8.0 5.6 143.6% View Chart
Dividend Yield % 1.1 0.5 228.5%  

Financials

 SANOFI INDIA   DR. REDDYS LAB
EQUITY SHARE DATA
    SANOFI INDIA
Dec-18
DR. REDDYS LAB
Mar-20
SANOFI INDIA/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs6,8403,363 203.4%   
Low Rs4,6302,352 196.9%   
Sales per share (Unadj.) Rs1,203.11,054.2 114.1%  
Earnings per share (Unadj.) Rs165.3121.9 135.5%  
Cash flow per share (Unadj.) Rs209.9190.2 110.3%  
Dividends per share (Unadj.) Rs84.0025.00 336.0%  
Dividend yield (eoy) %1.50.9 167.4%  
Book value per share (Unadj.) Rs963.6938.7 102.7%  
Shares outstanding (eoy) m23.03166.17 13.9%   
Bonus / Rights / Conversions -ESOP-  
Price / Sales ratio x4.82.7 175.9%   
Avg P/E ratio x34.723.4 148.1%  
P/CF ratio (eoy) x27.315.0 181.9%  
Price / Book Value ratio x6.03.0 195.5%  
Dividend payout %50.820.5 247.9%   
Avg Mkt Cap Rs m132,078474,831 27.8%   
No. of employees `0003.321.7 15.2%   
Total wages/salary Rs m4,06833,802 12.0%   
Avg. sales/employee Rs Th8,393.88,091.0 103.7%   
Avg. wages/employee Rs Th1,232.41,561.3 78.9%   
Avg. net profit/employee Rs Th1,153.0935.8 123.2%   
INCOME DATA
Net Sales Rs m27,708175,170 15.8%  
Other income Rs m8976,206 14.5%   
Total revenues Rs m28,605181,376 15.8%   
Gross profit Rs m6,23524,421 25.5%  
Depreciation Rs m1,02711,348 9.1%   
Interest Rs m7983 0.7%   
Profit before tax Rs m6,09818,296 33.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m0561 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,292-1,403 -163.4%   
Profit after tax Rs m3,80620,260 18.8%  
Gross profit margin %22.513.9 161.4%  
Effective tax rate %37.6-7.7 -490.1%   
Net profit margin %13.711.6 118.8%  
BALANCE SHEET DATA
Current assets Rs m15,922125,991 12.6%   
Current liabilities Rs m6,23572,141 8.6%   
Net working cap to sales %35.030.7 113.7%  
Current ratio x2.61.7 146.2%  
Inventory Days Days6473 87.1%  
Debtors Days Days21105 19.9%  
Net fixed assets Rs m7,53983,854 9.0%   
Share capital Rs m230831 27.7%   
"Free" reserves Rs m21,962155,157 14.2%   
Net worth Rs m22,192155,988 14.2%   
Long term debt Rs m01,304 0.0%   
Total assets Rs m29,839232,253 12.8%  
Interest coverage x872.119.6 4,446.9%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.90.8 123.1%   
Return on assets %12.89.1 139.7%  
Return on equity %17.213.0 132.0%  
Return on capital %27.512.6 218.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m7,58784,193 9.0%   
Fx outflow Rs m7,14539,616 18.0%   
Net fx Rs m44244,577 1.0%   
CASH FLOW
From Operations Rs m3,73929,841 12.5%  
From Investments Rs m-731-4,923 14.8%  
From Financial Activity Rs m-1,972-25,159 7.8%  
Net Cashflow Rs m1,036-266 -389.5%  

Share Holding

Indian Promoters % 0.0 25.5 -  
Foreign collaborators % 60.4 0.0 -  
Indian inst/Mut Fund % 14.4 5.4 266.7%  
FIIs % 14.6 35.3 41.4%  
ADR/GDR % 0.0 18.5 -  
Free float % 10.5 15.3 68.6%  
Shareholders   15,184 75,885 20.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   ASTRAZENECA PHARMA  DR. DATSONS LABS  CADILA HEALTHCARE  GSK PHARMA  PANACEA BIOTECH  

Compare SANOFI INDIA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

4 Reasons Why Sensex Surged 848 Points Today(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Related Views on News

SANOFI INDIA Announces Quarterly Results (2QFY21); Net Profit Up 5.0% (Quarterly Result Update)

Oct 29, 2020 | Updated on Oct 29, 2020

For the quarter ended September 2020, SANOFI INDIA has posted a net profit of Rs 1 bn (up 5.0% YoY). Sales on the other hand came in at Rs 7 bn (down 11.9% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (1QFY21); Net Profit Up 39.9% (Quarterly Result Update)

Aug 26, 2020 | Updated on Aug 26, 2020

For the quarter ended June 2020, SANOFI INDIA has posted a net profit of Rs 1 bn (up 39.9% YoY). Sales on the other hand came in at Rs 7 bn (down 5.0% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (4QFY20); Net Profit Down 8.1% (Quarterly Result Update)

May 21, 2020 | Updated on May 21, 2020

For the quarter ended March 2020, SANOFI INDIA has posted a net profit of Rs 854 m (down 8.1% YoY). Sales on the other hand came in at Rs 8 bn (up 9.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (1QFY20); Net Profit Down 2.2% (Quarterly Result Update)

Jul 31, 2019 | Updated on Jul 31, 2019

For the quarter ended June 2019, SANOFI INDIA has posted a net profit of Rs 974 m (down 2.2% YoY). Sales on the other hand came in at Rs 7 bn (up 9.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (1QFY20); Net Profit Down 2.2% (Quarterly Result Update)

Jul 31, 2019 | Updated on Jul 31, 2019

For the quarter ended June 2019, SANOFI INDIA has posted a net profit of Rs 974 m (down 2.2% YoY). Sales on the other hand came in at Rs 7 bn (up 9.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

More Views on News

Most Popular

Is Intraday Trading For You?(Fast Profits Daily)

May 13, 2021

Do you think you have what it takes to be an intraday trader? Find out in this video.

My Secret to Find Breakthrough Stocks(Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

Are the Stock Markets Deaf to Covid Agony?(Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

The Key to Profit from India's EV Revolution(Profit Hunter)

May 7, 2021

Stocks you must consider investing in before buying your first electric vehicle.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


May 17, 2021 (Close)

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA 5-YR ANALYSIS

COMPARE SANOFI INDIA WITH

MARKET STATS